ID   HX171c
AC   CVCL_M690
SY   HX171; HX/171; HX/171c
DR   Wikidata; Q54896991
RX   PubMed=2475347;
RX   PubMed=8347478;
CC   Doubling time: 36 hours (PubMed=2475347).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C180839; Cervical squamous cell carcinoma, not otherwise specified
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 8
//
RX   PubMed=2475347; DOI=10.1016/0277-5379(89)90417-3;
RA   Kelland, Lloyd R.
RA   Tonkin, Katia S.
RT   "In vitro chemosensitivity of four new carcinoma of the cervix cell
RT   lines: relationship to radiosensitivity.";
RL   Eur. J. Cancer Clin. Oncol. 25:1211-1218(1989).
//
RX   PubMed=8347478; DOI=10.1038/bjc.1993.322; PMCID=PMC1968570;
RA   Mellish, Kirste J.
RA   Kelland, Lloyd R.
RA   Harrap, Kenneth Reginald
RT   "In vitro platinum drug chemosensitivity of human cervical squamous
RT   cell carcinoma cell lines with intrinsic and acquired resistance to
RT   cisplatin.";
RL   Br. J. Cancer 68:240-250(1993).
//